As 2017 heads toward the final quarter and the time intended for the Drug Supply Chain Security Act (DSCSA) to implement step 1, i.e., all pharma manufacturers distributing only serialized primary containers into the supply chain, we’ve learned a few things.
The GTIN Adoption and Usage Model is a self-assessment tool for manufacturers and providers to gauge progress in adopting and using the Global Trade Item Number®.
Though DSCSA law remains unchanged, compliance penalties are delayed until Nov. 2018, and pharma companies will be able to implement far-reaching serializations solutions.
Supply Chain Wizard – a leading full-service global consulting firm specializing in serialization and traceability, as well as supply chain strategy and operational transformation programs – is hosting Pharma CMO Summit on April 4-5, 2017.
Sharp Packaging Services has purchased a range of serialization solutions from TraceLink in order to prepare for the next phase of rapidly approaching requirements under the U.S. Drug Supply Chain Security Act (DSCSA).
